Twist Bioscience (TWST) Depreciation and Depletion (2022 - 2026)

Twist Bioscience (TWST) has reported Depreciation and Depletion for 5 consecutive years, with $6.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Depreciation and Depletion changed 0.0% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $23.5 million (down 8.2% YoY), while the FY2025 annual figure was $23.8 million, down 12.82% from the prior year.
• Depreciation and Depletion improved to $6.1 million in Q1 2026 per TWST's latest filing, from $5.9 million in the prior quarter.
• Across five years, Depreciation and Depletion topped out at $7.3 million in Q3 2023 and bottomed at $3.9 million in Q4 2022.
• Historically, Depreciation and Depletion has averaged $6.2 million across 5 years, with a median of $6.1 million in 2024.
• Annual changes were most pronounced in 2023 — Depreciation and Depletion jumped 76.92% — and 2025, when it dropped 17.14%.
• Twist Bioscience's Depreciation and Depletion stood at $3.9 million in 2022, then soared by 76.92% to $6.9 million in 2023, then retreated by 11.59% to $6.1 million in 2024, then slipped by 3.28% to $5.9 million in 2025, then rose by 3.39% to $6.1 million in 2026.
• Business Quant data shows TWST's Depreciation and Depletion at $6.1 million in Q1 2026, $5.9 million in Q4 2025, and $5.7 million in Q3 2025.